OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Arepanrix

Influenza A [H5] Monovalent Vaccine, Adjuvanted

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Arepanrix
Proper name
Influenza A [H5] Monovalent Vaccine, Adjuvanted
Licence type
351(a)
BLA number
125419
Applicant
ID Biomedical Corporation of Quebec
Center
CBER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
0.5ML Injection Intramuscular Vial Disc November 22, 2013

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity